Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT T NAISMITH

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1871519090
CMS profile
356985
Location
SAINT LOUIS, MO

General Payments · PY2018–2024

$629,168.77

  • Reported across 480 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$79,089.46

65 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $31,790.70 16
TG THERAPEUTICS, INC. $12,722.76 13
Amgen Inc. $11,045.96 9
SANOFI-AVENTIS U.S. LLC $7,747.80 11
E.R. Squibb & Sons, L.L.C. $7,637.50 1
Genentech USA, Inc. $4,554.34 7
NOVARTIS PHARMACEUTICALS CORPORATION $3,478.36 7
Celgene Corporation $112.04 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $98,588.26 109
PY2019 $71,980.23 89
PY2020 $18,637.75 11
PY2021 $149,649.25 64
PY2022 $128,125.36 88
PY2023 $83,098.46 54
PY2024 $79,089.46 65

Payment records · PY2024 (65)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $120.42 12/17/2024 Food and Beverage Undisputed 01/23/2026 1117637763 CMS
Amgen Inc. $61.18 12/19/2024 Food and Beverage Undisputed 01/23/2026 1117637761 CMS
Amgen Inc. $757.18 12/19/2024 Travel and Lodging Undisputed 01/23/2026 1117637773 CMS
Amgen Inc. $3,300.00 12/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117637765 CMS
Amgen Inc. $550.00 12/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117637769 CMS
Amgen Inc. $757.18 12/23/2024 Travel and Lodging Undisputed 01/23/2026 1117637775 CMS
Amgen Inc. $1,650.00 12/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117637777 CMS
Amgen Inc. $3,300.00 12/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117637767 CMS
Amgen Inc. $550.00 12/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117637771 CMS
Celgene Corporation $112.04 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101116256 CMS
E.R. Squibb & Sons, L.L.C. $7,637.50 12/30/2024 Consulting Fee Undisputed 01/23/2026 1101351290 CMS
Genentech USA, Inc. $62.50 12/07/2024 Food and Beverage Undisputed 01/23/2026 1133098997 CMS
Genentech USA, Inc. $85.25 12/07/2024 Food and Beverage Undisputed 01/23/2026 1133099001 CMS
Genentech USA, Inc. $572.78 12/07/2024 Travel and Lodging Undisputed 01/23/2026 1133099005 CMS
Genentech USA, Inc. $3,440.00 12/07/2024 Consulting Fee Undisputed 01/23/2026 1133099009 CMS
Genentech USA, Inc. $264.59 12/07/2024 Travel and Lodging Undisputed 01/23/2026 1133099013 CMS
Genentech USA, Inc. $56.25 12/07/2024 Food and Beverage Undisputed 01/23/2026 1133099017 CMS
Genentech USA, Inc. $72.97 12/07/2024 Food and Beverage Undisputed 01/23/2026 1133099021 CMS
GENZYME CORPORATION $2,457.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 1139680417 CMS
GENZYME CORPORATION $6,006.00 02/07/2024 Consulting Fee Undisputed 01/23/2026 1139680421 CMS
GENZYME CORPORATION $2,457.00 03/07/2024 Consulting Fee Undisputed 01/23/2026 1139680425 CMS
GENZYME CORPORATION $2,047.50 04/05/2024 Consulting Fee Undisputed 01/23/2026 1139680441 CMS
GENZYME CORPORATION $1,638.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 1139680433 CMS
GENZYME CORPORATION $41.30 05/30/2024 Food and Beverage Undisputed 01/23/2026 1139680427 CMS
GENZYME CORPORATION $103.38 05/30/2024 Food and Beverage Undisputed 01/23/2026 1139680431 CMS
GENZYME CORPORATION $146.25 06/06/2024 Food and Beverage Undisputed 01/23/2026 1139680445 CMS
GENZYME CORPORATION $10,808.00 06/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139680447 CMS
GENZYME CORPORATION $328.73 06/06/2024 Travel and Lodging Undisputed 01/23/2026 1139680449 CMS
GENZYME CORPORATION $26.00 06/06/2024 Travel and Lodging Undisputed 01/23/2026 1139680451 CMS
GENZYME CORPORATION $681.04 06/06/2024 Travel and Lodging Undisputed 01/23/2026 1139680589 CMS
GENZYME CORPORATION $1,638.00 06/12/2024 Consulting Fee Undisputed 01/23/2026 1139680437 CMS
GENZYME CORPORATION $1,092.00 07/11/2024 Consulting Fee Undisputed 01/23/2026 1139680637 CMS
GENZYME CORPORATION $2,047.50 08/14/2024 Consulting Fee Undisputed 01/23/2026 1139680641 CMS
GENZYME CORPORATION $273.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1139680647 CMS
Novartis Pharmaceuticals Corporation $2,925.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 1087106060 CMS
Novartis Pharmaceuticals Corporation $22.19 02/15/2024 Food and Beverage Undisputed 01/23/2026 1087106054 CMS
Novartis Pharmaceuticals Corporation $95.20 02/25/2024 Food and Beverage Undisputed 01/23/2026 1087106056 CMS
Novartis Pharmaceuticals Corporation $152.65 02/29/2024 Food and Beverage Undisputed 01/23/2026 1087106058 CMS
Novartis Pharmaceuticals Corporation $119.90 04/15/2024 Food and Beverage Undisputed 01/23/2026 1087106062 CMS
Novartis Pharmaceuticals Corporation $135.89 05/29/2024 Food and Beverage Undisputed 01/23/2026 1087106064 CMS
Novartis Pharmaceuticals Corporation $27.53 09/20/2024 Food and Beverage Undisputed 01/23/2026 1087106068 CMS
SANOFI-AVENTIS U.S. LLC $1,518.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 1139680413 CMS
SANOFI-AVENTIS U.S. LLC $679.80 01/10/2024 Consulting Fee Undisputed 01/23/2026 1139680415 CMS
SANOFI-AVENTIS U.S. LLC $300.00 02/07/2024 Consulting Fee Undisputed 01/23/2026 1139680419 CMS
SANOFI-AVENTIS U.S. LLC $300.00 03/07/2024 Consulting Fee Undisputed 01/23/2026 1139680423 CMS
SANOFI-AVENTIS U.S. LLC $750.00 04/05/2024 Consulting Fee Undisputed 01/23/2026 1139680443 CMS
SANOFI-AVENTIS U.S. LLC $1,050.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 1139680435 CMS
SANOFI-AVENTIS U.S. LLC $600.00 06/12/2024 Consulting Fee Undisputed 01/23/2026 1139680439 CMS
SANOFI-AVENTIS U.S. LLC $750.00 07/11/2024 Consulting Fee Undisputed 01/23/2026 1139680639 CMS
SANOFI-AVENTIS U.S. LLC $450.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1139680643 CMS
SANOFI-AVENTIS U.S. LLC $1,050.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1139680649 CMS
SANOFI-AVENTIS U.S. LLC $300.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1139680651 CMS
TG Therapeutics, Inc. $12.42 02/27/2024 Food and Beverage Undisputed 01/23/2026 1136890062 CMS
TG Therapeutics, Inc. $113.21 02/27/2024 Food and Beverage Undisputed 01/23/2026 1136890090 CMS
TG Therapeutics, Inc. $582.97 04/27/2024 Travel and Lodging Undisputed 01/23/2026 1136890096 CMS
TG Therapeutics, Inc. $842.96 04/27/2024 Travel and Lodging Undisputed 01/23/2026 1136890108 CMS
TG Therapeutics, Inc. $4,185.00 04/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1136890122 CMS
TG Therapeutics, Inc. $114.47 04/27/2024 Travel and Lodging Undisputed 01/23/2026 1136890138 CMS
TG Therapeutics, Inc. $751.50 05/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1136890186 CMS
TG Therapeutics, Inc. $5,062.50 08/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1136890152 CMS
TG Therapeutics, Inc. $208.14 08/29/2024 Travel and Lodging Undisputed 01/23/2026 1136890176 CMS
TG Therapeutics, Inc. $84.16 08/29/2024 Food and Beverage Undisputed 01/23/2026 1136890192 CMS
TG Therapeutics, Inc. $116.61 08/29/2024 Travel and Lodging Undisputed 01/23/2026 1136890206 CMS
TG Therapeutics, Inc. $12.85 08/29/2024 Food and Beverage Undisputed 01/23/2026 1136890224 CMS
TG Therapeutics, Inc. $635.97 08/29/2024 Travel and Lodging Undisputed 01/23/2026 1136890234 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.